BioNano Genomics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; BioNano Genomics is scheduled to report earnings on August 9, 2023, and the estimated EPS forecast is €-0.98. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	$ 7.42M	$ 8.21M	$ 7.22M	$ 6.67M	$ 5.70M
Gross Profit	$ 2.07M	$ 1.80M	$ 1.81M	$ 1.47M	$ 861.00K
EBIT	$ -37.73M	$ -37.57M	$ -31.71M	$ -32.04M	$ -29.87M
EBITDA	$ -34.57M	$ -34.75M	$ -29.28M	$ -29.69M	$ -27.63M
Net Income Common Stockholders	$ -37.12M	$ -38.68M	$ -31.81M	$ -32.16M	$ -29.95M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 95.80M	$ 113.20M	$ 180.19M	$ 187.34M	$ 216.47M
Total Assets	$ 292.15M	$ 307.50M	$ 323.70M	$ 321.55M	$ 348.21M
Total Debt	$ 11.17M	$ 11.67M	$ 10.39M	$ 10.76M	$ 11.12M
Net Debt	$ -84.63M	$ -101.53M	$ -169.80M	$ -176.58M	$ -205.35M
Total Liabilities	$ 60.66M	$ 58.10M	$ 41.96M	$ 36.82M	$ 37.03M
Stockholders Equity	$ 231.49M	$ 249.40M	$ 281.74M	$ 284.73M	$ 311.19M
Cash Flow	-
Free Cash Flow	$ -32.40M	$ -34.73M	$ -29.76M	$ -28.80M	$ -33.48M
Operating Cash Flow	$ -32.40M	$ -34.52M	$ -29.47M	$ -28.33M	$ -32.49M
Investing Cash Flow	$ 16.53M	$ 11.61M	$ 7.95M	$ 31.24M	$ 31.96M
Financing Cash Flow	$ 14.86M	$ 146.00K	$ 22.65M	$ 203.00K	$ 7.00K

Currency in USD

BioNano Genomics Earnings and Revenue History

Income Statement >

BioNano Genomics Debt to Assets

Balance Sheet >

BioNano Genomics Cash Flow

Cash Flow >

BioNano Genomics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing